GSS vs MYX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

GSS

GENETICSIG FPO [GSS]

54MEDIUM

MYX

M PHARMA FPO [MYX]

51MEDIUM

Score Breakdown

GSS MYX
Technical
50
51
Catalyst
65
53
Sentiment
50
50
Fundamental
59
85
Momentum
31
38
Risk Gate
50
42

Key Metrics

GSS Metric MYX
$14.5MMarket Cap$233.2M
877KAvg Volume (20d)291K
N/AShort Interest+2.5%
$0.43052-Week High$6.500
$0.05752-Week Low$2.040
-1.6%Daily Change-0.7%
$0.063Reference Price$2.810
-22.8%ROE-20.6%
-56.5%Profit Margin-20.4%

Active Signals

GSS Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (12 quarters)
●Low P/S ratio (0.7x)
●EPS estimates revised downward (-10pts)
●Near 52-week low (2% of range)

MYX Signals

●Beating the Small Ords index — relative strength of 1.29, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.6x)
●EPS estimates revised upward (+10pts)
●Near 52-week low (19% of range)
●CANSLIM I: Institutional ownership (36%)
●Deeply negative margins (-20%)

Ask Scout AI to compare GSS and MYX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

GSS vs NTI →GSS vs OCC →GSS vs PHX →GSS vs PKY →GSS vs RHY →
GSS Full Analysis → MYX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).